SEARCH
Former FDA Advisor on Eli Lilly's Antibody Treatment
The Street
2020-10-08
Views
2
Description
Share / Embed
Download This Video
Report
Dr. Dan Fagbuyi, ER physician and biodefense expert, joined TheStreet's Katherine Ross to discuss Eli Lilly's antibody treatment.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7wpr4v" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:17
India gives emergency use approval to Eli Lilly’s Covid antibody drug
01:22
Eli Lilly's COVID-19 antibody drug gets interim authorization in Canada
04:22
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
00:29
FDA Advisory Committee Unanimously Approves Eli Lilly's Alzheimer's Drug as Safe and Effective
00:39
FDA Approves Eli Lilly's Alzheimer's Drug, Slowing the Progression of the Brain-Wasting Disease
01:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
00:38
Eli Lilly's Earnings Soar as Diabetes and Weight Loss Drugs Fuel Blockbuster Quarter
01:32
Eli Lilly's COVID-19 drug gets U.S. authorization
01:32
Eli Lilly's COVID-19 drug gets U.S. authorization
00:37
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
04:40
Eli Lilly's Alzheimer's moment has arrived after Biogen plows through the
01:32
Eli Lilly's COVID-19 drug gets U.S. authorization